Sensorion a pioneering, clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the appointment of Edwin Moses, former Chief Executive Officer of Ablynx, as Chairman of its Board of Directors.
July 6, 2020
· 5 min read
